These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 7319133

  • 1. The bioavailability of erythromycin stearate versus enteric-coated erythromycin base when taken immediately before and after food.
    Clayton D, Leslie A.
    J Int Med Res; 1981; 9(6):470-7. PubMed ID: 7319133
    [Abstract] [Full Text] [Related]

  • 2. The influence of food on the bioavailability of new formulations of erythromycin stearate and base.
    Rutland J, Berend N, Marlin GE.
    Br J Clin Pharmacol; 1979 Oct; 8(4):343-7. PubMed ID: 508509
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bioinequivalence of erythromycin ethylsuccinate and enteric-coated erythromycin pellets following multiple oral doses.
    Yakatan GJ, Rasmussen CE, Feis PJ, Wallen S.
    J Clin Pharmacol; 1985 Oct; 25(1):36-42. PubMed ID: 3871797
    [Abstract] [Full Text] [Related]

  • 6. Tolerance and efficacy of erythromycin stearate tablets versus enteric-coated erythromycin base capsules in the treatment of patients with acne vulgaris.
    Bleeker J.
    J Int Med Res; 1983 Oct; 11(1):38-41. PubMed ID: 6219902
    [Abstract] [Full Text] [Related]

  • 7. Influence of study design in assessing food effects on absorption of erythromycin base and erythromycin stearate.
    DiSanto AR, Chodos DJ.
    Antimicrob Agents Chemother; 1981 Aug; 20(2):190-6. PubMed ID: 7283417
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of food on absorption of erythromycin. A study of two derivatives, the stearate and the base.
    Malmborg AS.
    J Antimicrob Chemother; 1979 Sep; 5(5):591-9. PubMed ID: 500517
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Plasma levels following single and repeated doses of erythromycin estolate and erythromycin stearate.
    Welling PG, Elliott RL, Pitterle ME, Corrick-West HP, Lyons LL.
    J Pharm Sci; 1979 Feb; 68(2):150-5. PubMed ID: 423080
    [Abstract] [Full Text] [Related]

  • 15. Intra- and intersubject variation of erythromycin absorption from single-unit and multiple-unit enteric-coated products.
    Graffner C, Josefsson K, Stockman O.
    Biopharm Drug Dispos; 1986 Feb; 7(2):163-71. PubMed ID: 3708122
    [Abstract] [Full Text] [Related]

  • 16. [Bioavailability of formulations containing erythromycin base or stearate in soft enteric gelatin capsules].
    Springolo V.
    Boll Chim Farm; 1978 Feb; 117(2):113-21. PubMed ID: 743360
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Gastrointestinal behavior of orally administered radiolabeled erythromycin pellets in man as determined by gamma scintigraphy.
    Digenis GA, Sandefer EP, Parr AF, Beihn R, McClain C, Scheinthal BM, Ghebre-Sellassie I, Iyer U, Nesbitt RU, Randinitis E.
    J Clin Pharmacol; 1990 Jul; 30(7):621-31. PubMed ID: 2391393
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.